KalVista Pharmaceuticals, Inc.
US ˙ NasdaqGM ˙ US4834971032

SecurityKALV / KalVista Pharmaceuticals, Inc.
InstitutionAlliancebernstein L.p.
Latest Disclosed Ownership33,580 shares
Latest Disclosed Value $ 542,317
Alliancebernstein L.p. reports 16.09% decrease in ownership of KALV / KalVista Pharmaceuticals, Inc.

On May 15, 2026 - Alliancebernstein L.p. filed a 13F-HR form disclosing ownership of 33,580 shares of KalVista Pharmaceuticals, Inc. (US:KALV) valued at $675,965 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 40,020 shares of KalVista Pharmaceuticals, Inc.. This represents a change in shares of -16.09% during the quarter. The current value of the position is $904,981 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 33,580 -6,440 -16.09 542 -16.10 0.0002
2026-02-17 2025-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 40,020 0 0.00 646 32.65 0.0002
2025-11-14 2025-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 40,020 0 0.00 487 7.74 0.0002
2025-08-14 2025-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 40,020 0 0.00 452 -1.95 0.0001
2025-05-15 2025-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 40,020 0 0.00 462 36.39 0.0002
2025-02-12 2024-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 40,020 0 0.00 339 -27.00 0.0001
2024-11-14 2024-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 40,020 -2,430 -5.72 463 -7.40 0.0002
2024-08-14 2024-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 42,450 12,440 41.45 500 40.85 0.0002
2024-05-14 2024-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 30,010 0 0.00 356 -3.27 0.0001
2024-02-14 2023-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 30,010 -2,400 -7.41 368 17.63 0.0001
2023-11-14 2023-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 32,410 0 0.00 312 7.22 0.0001
2023-08-15 2023-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 32,410 6,710 26.11 292 44.06 0.0001
2023-05-15 2023-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 25,700 0 0.00 202 16.76 0.0001
2023-02-15 2022-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 25,700 8,636 50.61 174 -30.24 0.0001
2022-11-15 2022-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 17,064 1,964 13.01 248 66.44 0.0001
2022-08-15 2022-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 15,100 4,700 45.19 149 -2.61 0.0001
2022-05-13 2022-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 10,400 -1,800 -14.75 153 -4.97 0.0001
2022-02-14 2021-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 12,200 0 0.00 161 -24.41 0.0001
2021-11-10 2021-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 12,200 0 0.00 213 -27.05 0.0001
2021-07-30 2021-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 12,200 12,200 292 0.0001
2021-05-06 2021-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 0 -18,800 -100.00 0 -100.00
2021-02-08 2020-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 18,800 -900 -4.57 357 43.95 0.0002
2020-11-12 2020-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 19,700 0 0.00 248 4.20 0.0001
2020-08-13 2020-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 19,700 7,400 60.16 238 153.19 0.0001
2020-05-14 2020-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 12,300 2,200 21.78 94 -47.78 0.0001
2020-02-18 2019-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 10,100 0 0.00 180 53.85 0.0001
2019-11-14 2019-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 10,100 10,100 117 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.